Acer Therapeutics (NASDAQ:ACER) Announces Earnings Results
Acer Therapeutics (NASDAQ:ACER – Get Free Report) issued its quarterly earnings results on Monday. The biopharmaceutical company reported ($0.53) EPS for the quarter, missing analysts’ consensus estimates of ($0.13) by ($0.40), reports. The firm had revenue of $0.37 million during the quarter, compared to analysts’ expectations of $2.55 million. Acer Therapeutics Stock Down 17.9 % […]